Skip to content

Effect of L-theanine on depressive symptoms and cognitive functions

Effect of L-theanine on depressive symptoms and cognitive functions - Effect of L-theanine on depressive symptoms and cognitive functions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028603
Enrollment
30
Registered
2017-08-09
Start date
2017-06-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy person

Interventions

Taking L-theanine 200mg/day once a day for 4 weeks Taking placebo once a day for 4 weeks

Sponsors

Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry
Lead Sponsor
Department of Research and Development, Nutrition Division, Taiyo Kagaku Co. Ltd, Mie, Japan
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: People who have not been diagnosed with psychiatric disorders

Exclusion criteria

Exclusion criteria: First, people who have been diagnosed with psychiatric disorders. Second, people during pregnancy or so suspected. Third, people who suffer from any serious physical disorders.

Design outcomes

Primary

MeasureTime frame
Change in depressive symptoms before administration, after 4 weeks, 6 weeks, and 10 weeks after administration

Secondary

MeasureTime frame
Change in cognitive functions before administration, after 4 weeks, 6 weeks, and 10 weeks after administration

Countries

Japan

Contacts

Public ContactShinsuke Hidese

National Center of Neurology and Psychiatry Department of Mental Disorder Research, National Institute of Neuroscience

shidese@ncnp.go.jp042-341-2712

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026